So does investing in biotech stocks. However, not every biotech stock is super-risky. Mirum Pharmaceuticals (NASDAQ: MIRM) is ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

The person behind the initiation was Canaccord Genuity's Sumant Kulkami, who flagged Biohaven as a buy with a price target of ...

Revolution Medicines announces positive Phase 3 clinical trial results for its pancreatic cancer treatment.

Iovance Biotherapeutics argues that there is a meaningful opportunity here of more than 8,000 patients diagnosed annually in ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

As a result, since the start of the year, two formerly down-and-out stocks in these industries are outperforming the S&P 500.

Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...

Focused on infectious disease therapies, this biotech firm reported a notable insider sale amid a year of strong share price gains.

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes - the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) - ...